Patents by Inventor Arman Lurye

Arman Lurye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treatment of encephalopathy
    Patent number: 11083779
    Abstract: A method of treatment of encephalopathy, the method comprising decreasing concentration of glucose in a patient's blood stream to 1.6-3.6 mmol per liter by intravenous insulin administrating and consecutively administering the patient with single doses of a plurality of pharmacological solutions with a 30-second interval, wherein, first pharmacological solution administered to the patient is a pharmacological solution comprising a vascular medicine with pharmacological effect, wherein second pharmacological solution administered to the patient is a straight nootropic effected pharmacological composition, wherein third pharmacological solution administered to the patient is a peptide pharmacological composition, and wherein fourth pharmacological solution administered to the patient is a metabolic pharmacological composition.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: August 10, 2021
    Inventor: Arman Lurye
  • METHOD FOR TREATMENT OF ENCEPHALOPATHY
    Publication number: 20190275114
    Abstract: A method of treatment of encephalopathy, the method comprising decreasing concentration of glucose in a patient's blood stream to 1.6-3.6 mmol per liter by intravenous insulin administrating and consecutively administering the patient with single doses of a plurality of pharmacological solutions with a 30-second interval, wherein, first pharmacological solution administered to the patient is a pharmacological solution comprising a vascular medicine with pharmacological effect, wherein second pharmacological solution administered to the patient is a straight nootropic effected pharmacological composition, wherein third pharmacological solution administered to the patient is a peptide pharmacological composition, and wherein fourth pharmacological solution administered to the patient is a metabolic pharmacological composition.
    Type: Application
    Filed: August 29, 2018
    Publication date: September 12, 2019
    Inventor: Arman Lurye